Italy's Newron Pharmaceuticals Said to Be in Talks for a Sale to Santhera
Newron Pharmaceuticals SpA, the
Italian company developing a drug for Parkinson’s disease with
Merck KGaA, is in talks to be bought by Santhera Pharmaceuticals
Holding AG, a person familiar with the situation said.
A deal to buy Bresso, Italy-based Newron may be reached
within weeks, said the person, who declined to be identified
because the discussions aren’t public. Stefan Weber, Newron’s
chief financial officer, and Thomas Staffelbach, a spokesman for
Santhera in Liestal, Read more [...]